Your browser doesn't support javascript.
loading
Nut Consumptions as a Marker of Higher Diet Quality in a Mediterranean Population at High Cardiovascular Risk.
Bibiloni, Maria Del Mar; Julibert, Alicia; Bouzas, Cristina; Martínez-González, Miguel A; Corella, Dolores; Salas-Salvadó, Jordi; Zomeño, M Dolors; Vioque, Jesús; Romaguera, Dora; Martínez, J Alfredo; Wärnberg, Julia; López-Miranda, José; Estruch, Ramón; Bueno-Cavanillas, Aurora; Arós, Fernando; Tinahones, Francisco; Serra-Majem, Lluis; Martín, Vicente; Lapetra, José; Vázquez, Clotilde; Pintó, Xavier; Vidal, Josep; Daimiel, Lidia; Delgado-Rodríguez, Miguel; Matía, Pilar; Ros, Emilio; Fernández-Carrión, Rebeca; Garcia-Rios, Antonio; Zulet, M Angeles; Orozco-Beltrán, Domingo; Schröder, Helmut; Fitó, Montserrat; Bulló, Mónica; Basora, Josep; Cenoz, Juan Carlos; Diez-Espino, Javier; Toledo, Estefanía; Tur, Josep A.
Afiliação
  • Bibiloni MDM; CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain. mar.bibiloni@uib.es.
  • Julibert A; Research Group on Community Nutrition and Oxidative Stress, University of Balearic Islands, 07122 Palma de Mallorca, Spain. mar.bibiloni@uib.es.
  • Bouzas C; Health Research Institute of the Balearic Islands (IdISBa), 07120 Palma de Mallorca, Spain. mar.bibiloni@uib.es.
  • Martínez-González MA; CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain. aliciajulibert@gmail.com.
  • Corella D; Research Group on Community Nutrition and Oxidative Stress, University of Balearic Islands, 07122 Palma de Mallorca, Spain. aliciajulibert@gmail.com.
  • Salas-Salvadó J; Health Research Institute of the Balearic Islands (IdISBa), 07120 Palma de Mallorca, Spain. aliciajulibert@gmail.com.
  • Zomeño MD; CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain. cristinabouvel@gmail.com.
  • Vioque J; Research Group on Community Nutrition and Oxidative Stress, University of Balearic Islands, 07122 Palma de Mallorca, Spain. cristinabouvel@gmail.com.
  • Romaguera D; Health Research Institute of the Balearic Islands (IdISBa), 07120 Palma de Mallorca, Spain. cristinabouvel@gmail.com.
  • Martínez JA; CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain. mamartinez@unav.es.
  • Wärnberg J; Department of Preventive Medicine and Public Health, University of Navarra-IDISNA, 31008 Pamplona, Spain. mamartinez@unav.es.
  • López-Miranda J; Department of Nutrition, Harvard T. H. Chan School of Public Health, Boston, MA 02115, USA. mamartinez@unav.es.
  • Estruch R; CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain. dolores.corella@uv.es.
  • Bueno-Cavanillas A; Department of Preventive Medicine, University of Valencia, 46010 Valencia, Spain. dolores.corella@uv.es.
  • Arós F; CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain. jordi.salas@urv.cat.
  • Tinahones F; Human Nutrition Unit, Biochemistry and Biotechnology Department, IISPV, Universitat Rovira i Virgili, 43201 Reus, Spain. jordi.salas@urv.cat.
  • Serra-Majem L; Cardiovascular Risk and Nutrition Research Group (CARIN), Hospital del Mar Medical Research Institute (IMIM), 08003 Barcelona, Spain. mzomeno@imim.es.
  • Martín V; Human Nutrition Unit, Blanquerna-Ramon Llull University, 08022 Barcelona, Spain. mzomeno@imim.es.
  • Lapetra J; Miguel Hernandez University, ISABIAL-FISABIO, 46020 Alicante, Spain. vioque@umh.es.
  • Vázquez C; CIBER Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain. vioque@umh.es.
  • Pintó X; CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain. mariaadoracion.romaguera@ssib.es.
  • Vidal J; Health Research Institute of the Balearic Islands (IdISBa), 07120 Palma de Mallorca, Spain. mariaadoracion.romaguera@ssib.es.
  • Daimiel L; CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain. jalfmtz@unav.es.
  • Delgado-Rodríguez M; Department of Nutrition, Food Sciences, and Physiology, Center for Nutrition Research, University of Navarra, 31008 Pamplona, Spain. jalfmtz@unav.es.
  • Matía P; Cardiometabolics Nutrition Group, IMDEA Food, CEI UAM + CSIC, 28049 Madrid, Spain. jalfmtz@unav.es.
  • Ros E; CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain. jwarnberg@uma.es.
  • Fernández-Carrión R; School of Nursing, School of Health Sciences, University of Málaga-IBIMA, 29010 Málaga, Spain. jwarnberg@uma.es.
  • Garcia-Rios A; CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain. jlopezmir@gmail.com.
  • Zulet MA; Lipids and Atherosclerosis Unit, Department of Internal Medicine, Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Reina Sofia University Hospital, University of Cordoba, 14004 Córdoba, Spain. jlopezmir@gmail.com.
  • Orozco-Beltrán D; CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain. restruch@clinic.cat.
  • Schröder H; Department of Internal Medicine, IDIBAPS, Hospital Clinic, University of Barcelona, 08036 Barcelona, Spain. restruch@clinic.cat.
  • Fitó M; Miguel Hernandez University, ISABIAL-FISABIO, 46020 Alicante, Spain. abueno@ugr.es.
  • Bulló M; Department of Preventive Medicine, University of Granada, 18016 Granada, Spain. abueno@ugr.es.
  • Basora J; CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain. aborau@secardiologia.es.
  • Cenoz JC; Department of Cardiology, OSI ARABA, University Hospital Araba, University of the Basque Country UPV/EHU, 01006 Vitoria-Gasteiz, Spain. aborau@secardiologia.es.
  • Diez-Espino J; CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain. fjtinahones@hotmail.com.
  • Toledo E; Department of Endocrinology, Virgen de la Victoria Hospital, University of Málaga, 29010 Málaga, Spain. fjtinahones@hotmail.com.
  • Tur JA; CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain. lluis.serra@uplgc.es.
Nutrients ; 11(4)2019 Mar 30.
Article em En | MEDLINE | ID: mdl-30935087
ABSTRACT

BACKGROUND:

Nut consumption has been associated with improved nutrient adequacy and diet quality in healthy adult populations but this association has never been explored in individuals at high cardiovascular risk.

OBJECTIVE:

to assess the associations between consumption of nuts and nutrient adequacy and diet quality in a Mediterranean population at high cardiovascular risk.

DESIGN:

baseline assessment of nutritional adequacy in participants (n = 6060, men and women, with ages 55⁻75 years old, with overweight/obesity and metabolic syndrome) in the PREDIMED-PLUS primary cardiovascular prevention randomized trial.

METHODS:

nut intake was assessed using a validated food frequency questionnaire. Participants who reported consuming zero quantity of nuts were classified as 'non-nut consumers'. 'Nut consumers' were participants who reported consuming any quantity of nuts. Nineteen micronutrients were examined (vitamins B1, B2, B3, B6, B12, A, C, D, E and folic acid; Ca, K, P, Mg, Fe, Se, Cr, Zn, and iodine). The proportion of micronutrient inadequacy was estimated using the estimated average requirements (EAR) or adequate intake (AI) cut-points. Diet quality was also assessed using a 17-item Mediterranean dietary questionnaire (Mediterranean diet score, MDS), a carbohydrate quality index (CQI) and a fat quality index (FQI).

RESULTS:

eighty-two percent of participants were nut consumers (median of nut consumption 12.6 g/day; interquartile range 6.0⁻25.2). Nut consumers were less likely to be below the EAR for vitamins A, B1, B2, B6, C, D, E, folic acid, and Ca, Mg, Se and Zn than non-nut consumers. Nut consumers were also more likely to be above the AI for K and Cr than non-nut consumers. Nut consumers had lower prevalence of inadequate micronutrient intakes, but also higher CQI, higher FQI, and better scores of adherence to the Mediterranean diet (Mediterranean diet score, MDS).

CONCLUSIONS:

nut consumers had better nutrient adequacy, diet quality, and adherence to the MedDiet than those non-nut consumers.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Síndrome Metabólica / Dieta / Nozes / Obesidade Tipo de estudo: Clinical_trials / Etiology_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Síndrome Metabólica / Dieta / Nozes / Obesidade Tipo de estudo: Clinical_trials / Etiology_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article